Table 1.
Characteristics of patients subjected to intratumoral microdialysis.
| Patient | Age (years) | Tumor size | Grade (NHG) | ER (%) | PR (%) |
|---|---|---|---|---|---|
| Cohort # 1 | |||||
| 1 | 67 | 18 | 2 | >50 | >50 |
| 2 | 59 | 10 | 2 | >50 | 10 |
| 3 | 51 | 20 | 3 | >50 | 0 |
| 4 | 86 | 60 | 3 | >50 | >50 |
| 5 | 83 | 20 | 2 | >50 | >50 |
| 6 | 66 | 20 | 2 | >50 | 0 |
| Cohort # 2 | |||||
| 1 | 70 | 22 | 2 | >50 | >50 |
| 2 | 68 | 24 | 2 | >50 | >50 |
| 3 | 52 | 25 | 3 | >50 | 10–50 |
| 4 | 78 | 28 | 2 | >50 | >50 |
| 5 | 62 | 21 | 2 | >50 | >50 |
| 6 | 45 | 40 | 3 | 0 | 0 |
| 7 | 61 | 25 | 2 | >50 | >50 |
| 8 | 48 | 30 | 2 | >50 | >50 |
| 9 | 73 | 30 | 2 | >50 | < 5 |
| 10 | 57 | 27 | 1 | >50 | >50 |
| 11 | 66 | 60 | 2 | >50 | >50 |
One catheter was inserted within the breast cancer, and the another one was inserted in adjacent normal breast tissue the day before surgery. All cancers were HER-2 negative.
ER, estrogen receptor; PR, progesterone receptor.